Showing posts with label health. Show all posts
Showing posts with label health. Show all posts

Wednesday, June 19, 2019

Modified Starch Market To Reach USD 14,245 Million By 2022


The global Modified starch market will grow at a CAGR of 3.8% from 2017 to 2022 to reach USD $14,245 million by 2022, according to latest publication from Meticulous Research®. This is driven by favourable functional properties of modified starch in food industry, increasing demand for clean label products, growing convenience food sector, and abundant availability of maize. In addition, the increasing use of modified starch in energy drinks and non-carbonated soft drinks for low calories value expectation and growing use of modified starches as a fat replacer in many food applications are the other leading factors expected to propel the growth of the global modified starch market. However, the fluctuating raw material prices and increasing use of gum arabic is expected to hinder the growth of the market to some extent.
https://www.meticulousresearch.com/product/modified-starch-market-forecast-2022/

The global modified starch market is segmented by raw material (corn, potato, cassava, wheat and others), function (thickener, binder, stabilizer, emulsifier and other), application (food and beverages, textile industry, paper industry, pharmaceuticals, animal nutrition and others), and geography (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa).
The corn is estimated to be the largest raw material in the modified starch market in 2016, due to its abundant availability and wide range of applications in the food & beverage industry. However, the Cassava is expected to grow faster, as it is the most economic source of starch on a global level.

North America holds the major share in the global modified starch market followed by Asia-Pacific and Europe region. However, Asia-Pacific region possesses lucrative growth potential for the modified starch market during the forecast period. This is mainly attributed to the extensive customer base in these regions due to large base of population and growing convenience food sector. Most of the modified starch market in this region will be driven by developing countries such as India and China due to the increasing purchasing power, rising production volume of food and beverages and textile industries.
The leading companies have employed various strategies to expand their product offerings, global footprint, and augment their market share. The key strategies followed by most companies in the global modified starch market were new product developments, agreements and collaborations, and expansions. Expansions were the most preferred growth strategy adopted by the key players, during the period of 2014-2017, enabling companies to strengthen their manufacturing and R&D capabilities, to fulfill growing regional demand, and ensure a competitive edge in the global modified starch market. The key players in the global modified starch market are Ingredion Incorporated, Cargill Incorporated, Achier Daniels Midland Company, AGRANA Beteiligungs-AG, Emsland-Stärke GmbH, Grain Processing Corporation, Roquette Frères S.A., Tate & Lyle PLC, AVEBE U.A., and Global Bio-chem Technology Group Company Limited.
Key questions answered in the report-
  • Which are the high growth market segments in terms of raw material, applications, functions, types, regions and countries?
  • What is the historical market for modified starch market across the globe?
  • What are the market forecasts and estimates from the period 2015-2022?
  • What are the major drivers, restrains, threats, and opportunities in the global modified starch market?
  • What are the burning issues of the global modified starch market?
  • Who are the major players in the global modified starch market and what share of the market do they hold?
  • Who are the major players in various countries and what share of the market do they hold?
  • What are the competitive landscapes and who are the market leaders by sub-region in the global modified starch market?
  • What are the recent developments in the global modified starch market?
  • What are the different strategies adopted by the major players in the global modified starch market?
  • What are the geographical trends and high growth regions/ countries?
  • What are the local emerging players in the global modified starch market and how do they compete with the global players?
Meticulous Market Research Pvt. Ltd.
Khushal
Contact Sales- +91-744-7780008

Tuesday, May 21, 2019

Hospital/medical beds market Worth 3.14 Billion USD By 2023.


Hospital/Medical Beds Market by Product (Beds, Accessories), Area of Use (Critical, Bariatric, Med Surg, Pediatric, Maternal), Technology (Powered, Manual), Type of Care (Curative, Long Term), and End User (Hospital, Homecare, Elderly)-Global Forecast to 2023.
                                   
            

The global hospital/medical beds market is expected to grow at a CAGR of 4.8% from 2018 to reach USD 3.14 billion by 2023. The growth of this market will be driven by factors such as increasing elderly population coupled with growing prevalence of chronic diseases, growing number of hospitals, and launch of technologically advanced beds. Moreover, the emergence of smart beds and robotic beds, growing demand for beds in home care settings, growing demand from developing economies, and growing medical tourism further supports the growth of this market. However, rising preference to minimally invasive surgeries (eliminating necessity of longer hospital stays) and decreasing number of beds in public hospitals hinders the growth of this market to some extent.
Browse in-depth Report on:
The global hospital/medical beds market study presents historical market data in terms of values (2016 and 2017), estimated current data (2018), and forecasts for 2023-by product (beds, accessories), by area of use (critical care, long-term care, bariatric care, med-surg, homecare, pediatric, and maternal), by type of care (curative care, rehabilitative care, long-term care), by technology (manual, powered), by end user (hospitals, elderly care settings, homecare, and others), and geography. The study also evaluates industry competitors and analyzes the market at regional and country level.

Table of Contents:
·         Introduction
·         Research Methodology
·         Executive Summary
·         Market Insights
·         Hospital/Medical Beds Market, by Product
·          Hospital/Medical Beds Market, by Area of Use
·          Hospital/Medical Beds Market, by Type of Care
·          Hospital/Medical Beds Market, by Technology
·         Hospital/Medical Beds Market, by End User
·          Hospital Beds Market, by Geography
·          Competitive Landscape
·         Company Profiles

Request sample report on:

Key Players
The report includes competitive landscape based on extensive assessment of the key strategic developments adopted by the leading market participants in the industry over the past 5 years (2014-2018). The key players operating in the global hospital beds market are Stryker Corporation (U.S.), Hill-Rom Holding, Inc. (U.S.), Invacare Corporation (U.S.), Getinge AB (Sweden), Paramount Bed Holdings Co., Ltd. (Japan), Medline Industries, Inc. (U.S.), Joh. Stiegelmeyer GmBH & Co. KG (Germany), Gendron, Inc. (U.S.), LINET Group SE (Czech Republic), Joerns Healthcare LLC. (U.S.), Span-America Medical Systems, Inc. (U.S.), Savion Industries (Israel), and Malvestio Spa (Italy) among others.
Contact Info:
Khushal
Contact Sales- +1-646-781-8004

Cell Culture Market Worth $11.2 Billion by 2024.



The global cell culture market is expected to grow at a CAGR of 9.4% from 2018 to 2024 to reach $11.2 billion by 2024, driven by factors such as increase in life science research, growing prevalence of chronic diseases, and rising demand for the biopharmaceuticals.
              
The global cell culture market study presents historical market data in terms of value (2016 and 2017), estimated current data (2018), and forecasts for 2024– by product (consumables and equipment), application (bioproduction, diagnostics, cancer research, drug screening and development, and stem cell research), and end user (pharmaceutical and biotechnology companies, academic and research institutes, and diagnostic laboratories). The study also evaluates industry competitors and analyzes the market at regional and country level.
Browse in-depth Report on: 
The consumables contributed the largest share due to their frequent usage in large quantity for research and commercial bioproduction applications, academic research, and clinical diagnostic applications.
Based on application, bioproduction segment commanded the largest market share. This segment is also expected to witness the fastest growth attributed to growing research activities related to biopharmaceuticals and rising demand for biopharmaceuticals for treatment of various critical illnesses.
Table of Contents:
  • ·         Introduction
  • ·         Research Methodology
  • ·         Executive Summary
  • ·         Market Insights
  • ·         Cell Culture Market, by Product
  • ·         Cell Culture Market, by Application
  • ·         Cell Culture Market, by End-User
  • ·         Cell Culture Market, by Geography
  • ·         Competitive Landscape
  • ·         Company Profiles
  • ·         Appendix
  •  

Request sample report on:
Key Players
The report includes competitive landscape based on extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past 4 years (2015-2018). The key players profiled in the global cell culture market research report are Fujifilm Corporation (Japan), HiMedia Laboratories (India), Merck Group (Germany), GE Healthcare (U.S.), Agilent Technologies, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), PromoCell GmbH (Germany), Lonza (Switzerland), Corning Inc. (U.S.), Becton Dickinson (U.S.), CellGenix GmbH (Germany), InvivoGen (U.S.), Sartorius (Germany), and Eppendorf (Germany), among others.
Contact Info:
Khushal
Contact Sales- +1-646-781-8004

Friday, May 17, 2019

Infectious Disease Diagnostics Market by Product& Services, Technology, Disease Type, End User, Region and Geography–Global Forecast to 2025.


 Infectious disease diagnostic procedures are designed to diagnose and investigate the causative agent of an infectious disease. The increasing global prevalence of infectious diseases, growing awareness for early detection using specific diagnostic tests, growth in funding for research on infectious disease diagnostics, and shift in focus from centralized laboratories to decentralized point-of-care testing are the major factors driving the growth of the infectious disease diagnostics market.

The global infectious disease diagnostics market study presents historical market data in terms of values, estimated current data, and forecasts for 2025-by product (assays and kits, instruments, and software & services), technology (immunodiagnostics, clinical microbiology, Polymerase Chain Reaction (PCR), isothermal nucleic acid amplification technology (INAAT), DNA sequencing & Next-Generation Sequencing (NGS), DNA microarray, and other technologies), disease type (hepatitis, HIV, hospital-acquired infections, HPV, tuberculosis, influenza and other infectious diseases), end user hospital/clinical laboratories, reference laboratories, academics/research institutes, and other end user). The study also evaluates industry competitors and analyzes the market at regional and country level.
                                                                                                                                
Table of Contents:
·         Introduction 
·         Research Methodology 
·         Executive Summary 
·         Market insights
·         Global Infectious Disease Diagnostics Market, by Product and Services 
·         Global Infectious Disease Diagnostics Market, by Technology
·         Global Infectious Disease Diagnostics Market, by Disease Type 
·         Global Infectious Disease Diagnostics Market, by End User 
·         Infectious Disease Diagnostics Market, by Region
·         Competitive Landscape 
·         Company Profiles (Includes Business Overview, Financial Overview, Product Portfolio, and Strategic Developments)


Key Players:
The report includes competitive landscape based on extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past 4 years (2016-2019). The key players profiled in the global infectious disease diagnostics market research report are Abbott Laboratories (US), Danaher (US), Bio-Rad Laboratories (US), bioMérieux SA (France), F. Hoffmann-La Roche Ltd (Switzerland), BD (US), DiaSorin S.p.A. (Italy), Meridian Bioscience, Inc. (US), Quidel Corporation (US), and Thermo Fisher Scientific Inc. (US) among others.

Contact Info:
Khushal
Contact Sales- +1-646-781-8004